Compare Novavax Inc (NVAX) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Transocean Ltd — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Transocean Ltd trades at $5.23 (market cap $5.56B). The key difference: Transocean Ltd is far larger — about 4.3× Novavax Inc's market cap, and Transocean Ltd is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | RIG | |
|---|---|---|
Market Cap | $1.30B | $5.56B |
Sector | Health | Technology |
52-Week High | $11.19 | $7.58 |
52-Week Low | $6.22 | $2.64 |
Enterprise Value | $800.50M | $10.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
